| Name | Title | Contact Details |
|---|
AIMSCO is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
National HME is accredited by HQAA for Hospice Medical Equipment Services, as well as Clinical Respiratory Services. * National HME provides equipment for hospice patients 24/7 at no additional cost to the hospice program. * National HME provides simplified billing allowing your program more time to devote to patient care while reducing the hassle of HME bill reconciliation. Most contracts offered to hospice programs promote all-inclusive packaging with minimal extra charges allowing you the peace of mind that comes with understanding the exact cost for HME. * National HME maintains a minimal amount of warehoused equipment to streamline and work efficiently in our distribution centers. With new contracts equipment will be purchased for your initial deliveries and start up. This will bring a sense of revitalization to your staff and patients, enhancing morale and improving referrals. * Our staff at National HME are specifically trained to understand the process of the hospice industry; including death and dying, dealing with emotional and difficult family situations while showing compassion and empathy. We have extensive competency requirements for every employee that works at National HME. * Training for the family and care givers is extensive including detailed written materials provided. * We utilize modern technology that allows for web based ordering, a paperless delivery system that provides real time delivery and better control of the assets of the company. In the near future, we expect our equipment to have RFID technology that will allow us to find misplaced items in facilities more efficiently.
Institute for Functional Medicine is a Gig Harbor, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Quality Assured Services, Inc. is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our vision is to free diabetics from the painful finger prick and throughout this leverage for our shareholders the significant market potential that such a non-invasive glucose monitor could achieve.